PVI
EVH icon

Pura Vida Investments’s Evolent Health EVH Stock Holding History

Pura Vida Investments’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-221,300
Closed -$6.86M – 259
2021
Q3 		$6.86M Buy
+221,300
New +$5.31M 0.21% 124

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Pura Vida Investments's EVH Position: Q1 2024 in Review

Pura Vida Investments sold out of Evolent Health (EVH) in Q1 2024, closing a stake of 64,573 shares — an estimated $2.13M sold.

Pura Vida Investments first reported a position in EVH in Q3 2021 and held it in 7 quarters. The position peaked at $8.53M in Q3 2021. 251 funds tracked by Wall St. Rank hold EVH as of Q1 2024.

  • Pura Vida Investments reported no remaining Evolent Health position as of Q1 2024 after selling out during the quarter.
  • Pura Vida Investments sold 64,573 Evolent Health shares in Q1 2024, an estimated $2.13M.
  • Pura Vida Investments first reported a position in Evolent Health in Q3 2021 and held it in 7 quarters.
  • Pura Vida Investments's Evolent Health position peaked at $8.53M in Q3 2021.
  • 251 funds tracked by Wall St. Rank held Evolent Health as of Q1 2024.

Based on Pura Vida Investments's 13F filing for Q1 2024, filed 15 May 2024.